Facial dermis grafts after removal of basal cell carcinomas

Seung-Kyu Han, Won Young Yoon, Seong-Ho Jeong, Woo-Kyung Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Selecting a proper reconstruction method is the key to success in skin cancer management, especially for lesions involving the face. Using a skin graft is usually straightforward when covering a skin defect; however, major concerns in skin grafting include a poor color match in the recipient-site and donor-site morbidity. To overcome these limitations, the authors have developed a dermis graft, which utilizes a de-epithelialized split-thickness skin graft method. The purpose of this retrospective study was to report reliability of dermis grafts after removal of basal cell carcinomas (BCCs) on the face by presenting our clinical experience with them. This study included 38 patients who were treated for facial defects created by resection of BCCs. The locations of the defects were as follows: nose (n = 17), orbital area (n = 14), cheek (n = 4), temple area (n = 2), and forehead (n = 1). The defects ranged in size from 3.3 to 6.5 cm2. Functional and cosmetic outcomes, postoperative complications, and patient satisfaction were assessed. The patients were followed up for 12 to 36 months. The entire dermis graft reepithelialized after grafting within 17 to 27 days. Most of the patients had satisfactory results in both functional and cosmetic matters with high-quality skin characteristics. There were no significant complications and no recurrences were observed during the follow-up period. Patient satisfaction with the dermis graft was also excellent. The dermis graft may be used reliably for covering defects after removal of BCCs on the face.

Original languageEnglish
Pages (from-to)1895-1897
Number of pages3
JournalJournal of Craniofacial Surgery
Volume23
Issue number6
DOIs
Publication statusPublished - 2012 Nov 1

Fingerprint

Basal Cell Carcinoma
Dermis
Transplants
Skin
Patient Satisfaction
Cosmetics
Skin Transplantation
Forehead
Cheek
Skin Neoplasms
Prefrontal Cortex
Nose
Retrospective Studies
Color
Tissue Donors
Morbidity
Recurrence

Keywords

  • Basal cell carcinoma
  • Dermis graft
  • Skin graft

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Facial dermis grafts after removal of basal cell carcinomas. / Han, Seung-Kyu; Yoon, Won Young; Jeong, Seong-Ho; Kim, Woo-Kyung.

In: Journal of Craniofacial Surgery, Vol. 23, No. 6, 01.11.2012, p. 1895-1897.

Research output: Contribution to journalArticle

Han, Seung-Kyu ; Yoon, Won Young ; Jeong, Seong-Ho ; Kim, Woo-Kyung. / Facial dermis grafts after removal of basal cell carcinomas. In: Journal of Craniofacial Surgery. 2012 ; Vol. 23, No. 6. pp. 1895-1897.
@article{ece25b7ee5a34a589d08d7d07b933306,
title = "Facial dermis grafts after removal of basal cell carcinomas",
abstract = "Selecting a proper reconstruction method is the key to success in skin cancer management, especially for lesions involving the face. Using a skin graft is usually straightforward when covering a skin defect; however, major concerns in skin grafting include a poor color match in the recipient-site and donor-site morbidity. To overcome these limitations, the authors have developed a dermis graft, which utilizes a de-epithelialized split-thickness skin graft method. The purpose of this retrospective study was to report reliability of dermis grafts after removal of basal cell carcinomas (BCCs) on the face by presenting our clinical experience with them. This study included 38 patients who were treated for facial defects created by resection of BCCs. The locations of the defects were as follows: nose (n = 17), orbital area (n = 14), cheek (n = 4), temple area (n = 2), and forehead (n = 1). The defects ranged in size from 3.3 to 6.5 cm2. Functional and cosmetic outcomes, postoperative complications, and patient satisfaction were assessed. The patients were followed up for 12 to 36 months. The entire dermis graft reepithelialized after grafting within 17 to 27 days. Most of the patients had satisfactory results in both functional and cosmetic matters with high-quality skin characteristics. There were no significant complications and no recurrences were observed during the follow-up period. Patient satisfaction with the dermis graft was also excellent. The dermis graft may be used reliably for covering defects after removal of BCCs on the face.",
keywords = "Basal cell carcinoma, Dermis graft, Skin graft",
author = "Seung-Kyu Han and Yoon, {Won Young} and Seong-Ho Jeong and Woo-Kyung Kim",
year = "2012",
month = "11",
day = "1",
doi = "10.1097/SCS.0b013e31825b384a",
language = "English",
volume = "23",
pages = "1895--1897",
journal = "Journal of Craniofacial Surgery",
issn = "1049-2275",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Facial dermis grafts after removal of basal cell carcinomas

AU - Han, Seung-Kyu

AU - Yoon, Won Young

AU - Jeong, Seong-Ho

AU - Kim, Woo-Kyung

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Selecting a proper reconstruction method is the key to success in skin cancer management, especially for lesions involving the face. Using a skin graft is usually straightforward when covering a skin defect; however, major concerns in skin grafting include a poor color match in the recipient-site and donor-site morbidity. To overcome these limitations, the authors have developed a dermis graft, which utilizes a de-epithelialized split-thickness skin graft method. The purpose of this retrospective study was to report reliability of dermis grafts after removal of basal cell carcinomas (BCCs) on the face by presenting our clinical experience with them. This study included 38 patients who were treated for facial defects created by resection of BCCs. The locations of the defects were as follows: nose (n = 17), orbital area (n = 14), cheek (n = 4), temple area (n = 2), and forehead (n = 1). The defects ranged in size from 3.3 to 6.5 cm2. Functional and cosmetic outcomes, postoperative complications, and patient satisfaction were assessed. The patients were followed up for 12 to 36 months. The entire dermis graft reepithelialized after grafting within 17 to 27 days. Most of the patients had satisfactory results in both functional and cosmetic matters with high-quality skin characteristics. There were no significant complications and no recurrences were observed during the follow-up period. Patient satisfaction with the dermis graft was also excellent. The dermis graft may be used reliably for covering defects after removal of BCCs on the face.

AB - Selecting a proper reconstruction method is the key to success in skin cancer management, especially for lesions involving the face. Using a skin graft is usually straightforward when covering a skin defect; however, major concerns in skin grafting include a poor color match in the recipient-site and donor-site morbidity. To overcome these limitations, the authors have developed a dermis graft, which utilizes a de-epithelialized split-thickness skin graft method. The purpose of this retrospective study was to report reliability of dermis grafts after removal of basal cell carcinomas (BCCs) on the face by presenting our clinical experience with them. This study included 38 patients who were treated for facial defects created by resection of BCCs. The locations of the defects were as follows: nose (n = 17), orbital area (n = 14), cheek (n = 4), temple area (n = 2), and forehead (n = 1). The defects ranged in size from 3.3 to 6.5 cm2. Functional and cosmetic outcomes, postoperative complications, and patient satisfaction were assessed. The patients were followed up for 12 to 36 months. The entire dermis graft reepithelialized after grafting within 17 to 27 days. Most of the patients had satisfactory results in both functional and cosmetic matters with high-quality skin characteristics. There were no significant complications and no recurrences were observed during the follow-up period. Patient satisfaction with the dermis graft was also excellent. The dermis graft may be used reliably for covering defects after removal of BCCs on the face.

KW - Basal cell carcinoma

KW - Dermis graft

KW - Skin graft

UR - http://www.scopus.com/inward/record.url?scp=84873288608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873288608&partnerID=8YFLogxK

U2 - 10.1097/SCS.0b013e31825b384a

DO - 10.1097/SCS.0b013e31825b384a

M3 - Article

C2 - 23172436

AN - SCOPUS:84873288608

VL - 23

SP - 1895

EP - 1897

JO - Journal of Craniofacial Surgery

JF - Journal of Craniofacial Surgery

SN - 1049-2275

IS - 6

ER -